Inovio Pharmaceuticals Company
Inovio Pharmaceuticals engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline include VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP.
Investors
.png)
Funding Status:
N/A
Industry:
Genomic and Epigenominc Instabillity
Number Of Exists:
N/A
Technology:
COVID
Founded Date:
N/A
Investor Type:
N/A
Headquarters:
United States
Employee Number:
N/A
Investment Stage:
N/A